| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies | Company's Home Page |
| Natus Medical Incorporated |
| 150 Industrial Road, San Carlos, CA 94070 * (650) 802-0400 |
| Business Description | The company is a medical device company focused on developing, manufacturing and marketing screening products for the identification and monitoring of common medical disorders that may occur in the critical developmental period from conception to a baby's first birthday. |
| Offering Information Company has | |||
| Trading As | BABY (NASNTL) | Industry | Manufacturing (SIC 3845) |
| Type of Stock Offered | Common Shares | Filing Date | 8/18/2000 |
| Domestic Shares Offered | 5,000,000 | Offer Date | 7/19/2001 |
| Foreign Shares Offered | 0 | Filing Range | $10.00 - $12.00 |
| Company Shares | 5,000,000 | Offer Price | $11.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.770 |
| Gross Proceeds | $55,000,000 | Selling | $0.460 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 14,840,000 | Employees | 101 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Dain Rauscher Wessels | Lead Manager | (612) 371-2818 |
| First Union Capital Markets Corp. | Co-manager | (804) 649-2311 |
| Prudential Vector Healthcare | Co-manager | (800) 546-1231 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1995 | 12/31/1996 | 12/31/1997 | 12/31/1998 | 12/31/1999 | 6/30/1999 | 6/30/2000 |
| Revenues | 4.274 | 6.501 | 10.031 | 15.884 | 19.783 | 8.918 | 11.009 |
| Income from Oper. | -1.151 | -0.685 | -0.673 | -0.317 | 0.634 | -0.127 | -0.329 |
| Net Income | -1.163 | -0.664 | -0.576 | -0.199 | 0.644 | -0.122 | -0.317 |
| E.P.S | -20.550 | -16.290 | -7.620 | -3.630 | -2.560 | -1.470 | -1.590 |
| Revenue Growth (%) | 52.11 | 54.30 | 58.35 | 24.547 | 23.45 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | 3.20 | - | - |
| Net Profit Margin (%) | - | - | - | - | 3.26 | - | - |
| Cash Flow - Oper. | 1.25 | 0.47 | -1.59 | ||||
| Cash Flow - Inv. | -1.35 | -0.73 | -0.41 | ||||
| Cash Flow - Fin. | 0.52 | -0.03 | 0.00 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/2000 | Financial Ratios | ||||
| Total Assets | 9.06 | Current Assets | 7.20 | Current Ratio | 2.16 |
| Total Liab. | 27.87 | Current Liab. | 3.34 | Debt Ratio | 307.65% |
| Total Equity | -18.81 | Working Cap. | 3.86 | Debt to Equity Ratio | - |
| Cash | 1.51 | Return on Assets | 7.11% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to fund international expansion, working capital, capital expenditures, general corporate purposes and potential acquisitions of complementary businesses, products and technologies. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Wilson, Sonsini, Goodrich & Rosati |
| Bank's Law Firm | Cravath, Swaine & Moore |
| Registrar/Transfer Agent | EquiServe |
| Auditor | Deloitte & Touche |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Trinity Ventures Entities | 14.50 | |
| Delphi Ventures Entities | 14.10 | |
| Pantheon International Participations PLC | 9.80 | |
| Landmark Equity Partners V, L.P. | 8.80 | |
| John Porter Entities | 7.80 | |
| Nikko Capital Entities | 5.00 | |
| Note: represents ownership of 5% or more prior to the offering. | ||